Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Thyroid Gland Papillary Carcinoma”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06087068
What this trial is testing

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerSurgeryRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Study completedNCT00118248
What this trial is testing

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer+1 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00098813
What this trial is testing

Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

Who this might be right for
Recurrent Thyroid CancerStage IV Follicular Thyroid CancerStage IV Papillary Thyroid Cancer
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03914300
What this trial is testing

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Gland CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaPoorly Differentiated Thyroid Gland Carcinoma+6 more
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Ended earlyNCT00095693
What this trial is testing

Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerRecurrent Thyroid Cancer+4 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)UnknownNCT00098852
What this trial is testing

Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 25
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Testing effectiveness (Phase 2)Study completedNCT00026533
What this trial is testing

Thalidomide in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Kenneth Ain
Testing effectiveness (Phase 2)Study completedNCT00061906
What this trial is testing

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Ohio State University Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01811212
What this trial is testing

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

Who this might be right for
Poorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaStage I Thyroid Gland Follicular Carcinoma+13 more
National Cancer Institute (NCI) 25
Large-scale testing (Phase 3)UnknownNCT00415233
What this trial is testing

High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
University College, London 438
Testing effectiveness (Phase 2)Study completedNCT00537095
What this trial is testing

Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Genzyme, a Sanofi Company 164
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Testing effectiveness (Phase 2)Study completedNCT00729157
What this trial is testing

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Thyroid Gland Follicular CarcinomaStage III Thyroid Gland Papillary Carcinoma+2 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT00085293
What this trial is testing

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00134043
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer

Who this might be right for
Insular Thyroid CancerRecurrent Thyroid CancerStage II Follicular Thyroid Cancer+4 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00668811
What this trial is testing

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerDifferentiated Thyroid Cancer
Medstar Health Research Institute 23
Load More Results